@misc{indiciae5feafb1f493c,
  title = {TRAIL receptor agonist TLY012 in combination with PD-1 inhibition promotes tumor regression in an immune-competent mouse model of pancreatic ductal adenocarcinoma},
  author = {Louie, A. D. and Huntington, K. E. and Lee, Y. and Mompoint, J. and Wu, L. J. and Lee, S. and Miner, T. J. and El-Deiry, W. S.},
  year = {2024},
  doi = {10.1101/2024.08.29.610345},
  url = {https://www.biorxiv.org/content/10.1101/2024.08.29.610345v1},
  note = {Source identifier: 10.1101/2024.08.29.610345}
}